Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Mutations in the DSG4 gene can cause a rare hair disorder similar to monilethrix.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

The new assay can track and measure melanosome transfer between skin cells, confirming filopodia's role in this process.

Some chemotherapy can cause permanent hair loss.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

Hedgehog signaling helps keep hair follicle stem cells the same in both young and old human skin.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Wnt signaling may be linked to heart diseases in aging and could be a target for future treatments.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

Genetics and hormones cause hair loss; finasteride treats it safely.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Choosing the right shampoo for your hair type is crucial.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.